Bodily substance detection by evaluating photoluminescent response to excitation radiation

US10709505B2 · kind B2 · utility

Assignee

• Boston Scientific Limited · BB

Inventors

• Ralf Brinkmann · Grevenbroich, DE
• Birgit Lange · Lübeck, DE

Key dates

• Filing date: Jun 9, 2016
• Grant date: Jul 14, 2020
• Expiry date: Aug 19, 2037

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61B2018/00904
• WIPO field: Medical technology
• WIPO sector: Instruments

Abstract

A medical device may include an ablation device configured to deliver ablation energy to a treatment site. The medical device may further include a probe device configured to deliver excitation radiation to the treatment site. Further the medical device may include a radiation-receiving device configured to receive photoluminescence radiation emitted from the treatment site in response to the treatment site being illuminated by the excitation radiation and to generate a detection signal in response to the received photoluminescence radiation. Additionally, the excitation radiation may be different from the ablation energy.